[Chemotherapy of virus diseases].
D000547:Amantadine / Q000031:analogs & derivatives / Q000627:therapeutic use; D001645:Biguanides; D005814:Genes, Viral; D006801:Humans; D007542:Inosine Pranobex / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012897:Slow Virus Diseases / Q000188:drug therapy; D014759:Viral Envelope Proteins; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication
D001645:Biguanides; D009025:Morpholines; D009705:Nucleosides; D011687:Purines; D011743:Pyrimidines; D014759:Viral Envelope Proteins; D000547:Amantadine; C004279:tromantadine; C005267:moroxydine; D007542:Inosine Pranobex
Chemotherapie von Viruskrankheiten.